ADVFN Logo
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

AGLE Aeglea BioTherapeutics Inc

12.01
0.00 (0.00%)
Last Updated: 20:00:00
Delayed by 15 minutes

Aeglea BioTherapeutics Financial Summary

The current AGLE market cap is 48.63M. The company's latest EPS is USD -83.6725 and P/E is -0.45.

Quarter End Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023
USD ($)USD ($)USD ($)USD ($)USD ($)
Total Revenue 174k168k198k688k0
Operating Income -18.76M-19.16M-18.81M-159.25M-32.95M
Net Income -18.23M-18.82M-18.42M-217.08M-40.16M
Year End December 30 2023 20192020202120222023
USD ($)USD ($)USD ($)USD ($)USD ($)
Total Revenue 0018.74M2.33M886k
Operating Income -80.33M-81.48M-65.65M-84.78M-258.75M
Net Income -78.25M-80.89M-65.8M-83.82M-338.79M
Quarter End Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023
USD ($)USD ($)USD ($)USD ($)USD ($)
Total Assets 91.57M71.14M52.45M243.53M207.27M
Total Liabilities 24.01M20.84M18.8M253.58M65.56M
Total Equity 67.56M50.31M33.65M-207.37M-245.4M
Year End December 30 2023 20192020202120222023
USD ($)USD ($)USD ($)USD ($)USD ($)
Total Assets 83.18M161.62M109.93M71.14M341.86M
Total Liabilities 23.1M21.79M25.99M20.84M73.29M
Total Equity 60.08M139.83M83.94M50.31M184.02M
Quarter End Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023
USD ($)USD ($)USD ($)USD ($)USD ($)
Operating -62M-80.14M-17.63M-34.28M-68.87M
Investing 43.01M57.01M17.75M24.51M-73.12M
Financing 42.69M42.68M10k210M197.47M
Year End December 30 2023 20192020202120222023
USD ($)USD ($)USD ($)USD ($)USD ($)
Operating -65.69M-75.78M-53.72M-80.14M-99.91M
Investing -1.74M-7.6M-22.62M57.01M-108.39M
Financing 65.72M154.51M1.39M42.68M361.08M
Market Cap 48.63M
Price to Earnings Ratio -0.45
Price to Sales Ratio 171.98
Price to Cash Ratio 0.81
Price to Book Ratio 0.57
Dividend Yield -

Share Statistics

Shares Outstanding 4.05M
Average Volume (1 week) 0
Average Volume (1 Month) 0
52 Week Change 54.12%
52 Week High 24.00
52 Week Low 2.66
Spread (Intraday) 2.8 (20%)

Company Info

Company Name Aeglea BioTherapeutics Inc
Address 1521 concord pike
wilmington, delaware 19803
Website https://www.spyre.com
Industry pharmaceutical preparations (2834)

Your Recent History

Delayed Upgrade Clock